Lemaitre Vascular (LMAT) Gross Margin (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Gross Margin of 72.72% for Q1 2026, up 354.0% year-over-year from 16.02% in Q1 2025, and up 1.47% quarter-over-quarter from 71.66% in Q4 2025.
Lemaitre Vascular (LMAT) Gross Margin (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Gross Margin for 17 consecutive years, with 72.72% the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Margin rose 354.0% year-over-year to 72.72%; the TTM figure through Mar 2026 stood at 72.39% (up 359.0% YoY), while the FY2025 annual figure was 71.53%, up 290.0% from the prior year.
- Gross Margin improved to 72.72% in Q1 2026 per LMAT's latest filing, from 71.66% in the prior quarter.
- Across five years, Gross Margin topped out at 75.28% in Q3 2025 and bottomed at 63.62% in Q4 2022.
- Historically, Gross Margin has averaged 67.98% across 5 years, with a median of 68.05% in 2023.
- Annual changes were most pronounced in 2022 — Gross Margin plunged 209 bps — and 2025, when it soared 746 bps.
- Lemaitre Vascular's Gross Margin stood at 63.62% in 2022, then climbed by 7 bps to 68.05% in 2023, then gained by 2 bps to 69.26% in 2024, then increased by 3 bps to 71.66% in 2025, then climbed by 1 bps to 72.72% in 2026.
- Business Quant data shows LMAT's Gross Margin at 72.72% in Q1 2026, 71.66% in Q4 2025, and 75.28% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 67.78% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 46.46% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 59.33% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 58.84% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 28.82% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 37.74% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 58.22% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 68.00% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 34.86% |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 72.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.13% |
| Mar 31, 2026 | 72.72% |
| Dec 31, 2025 | 71.66% |
| Sep 30, 2025 | 75.28% |
| Jun 30, 2025 | 70.02% |
| Mar 31, 2025 | 69.18% |
| Dec 31, 2024 | 69.26% |
| Sep 30, 2024 | 67.82% |
| Jun 30, 2024 | 68.88% |
| Mar 31, 2024 | 68.56% |
| Dec 31, 2023 | 68.05% |
| Sep 30, 2023 | 65.00% |
| Jun 30, 2023 | 64.02% |
| Mar 31, 2023 | 65.60% |
| Dec 31, 2022 | 63.62% |
| Sep 30, 2022 | 64.24% |
| Jun 30, 2022 | 66.04% |
| Mar 31, 2022 | 65.63% |
| Dec 31, 2021 | 65.71% |
| Sep 30, 2021 | 64.81% |